Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer
Latest Information Update: 05 Jul 2019
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Urogenital cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 05 Jul 2019 New trial record
- 01 Jul 2019 Results assessing therapeutic outcomes and safety profiles of pembrolizumab in Japanese patients with metastatic Urothelial cancer published in the Anticancer Research